Evidence map›Paper›PMID 40374693›Full record

ArticleNature communications2025

Full-color processible afterglow organic small molecular glass.

Yufeng Xue, Zongliang Xie, Zheng Yin, Yincai Xu, Bin Liu

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Luminescent Chiral Molecular Glasses by Melt-Quenching Enantiopure BINAP.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Bullvalene-Containing Molecular Glasses.Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yufeng XueDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.
Zongliang XieDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0002-1890-5057
Zheng YinDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.
Yincai XuDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.
Bin LiuDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore. cheliub@nus.edu.sg.ORCID http://orcid.org/0000-0002-0956-2777

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organic afterglow materials, known for their unique luminescent properties and diverse applications, have garnered significant attention in recent years. However, developing long-lasting, high-efficiency, full-color afterglow systems and exploring simple materials processing strategies for new applications are still challenging in this field. Herein, we rationally design a processable molecular glass and employ it as a host in a host-guest strategy to address these challenges. By strategically modifying the host via othyl-methylation, we successfully create a molecular glass and capture its temperature-dependent, processable viscous supercooled liquid state. High-efficiency full color from violet to near-infrared afterglow systems with ultralong lifetimes are developed by doping varied structural dopants. The underlying glass-forming and afterglow mechanisms are also clearly elucidated and verified. Moreover, the excellent glass-forming ability of the host and its viscous supercooled liquid enabled the glass system for large-area fabrication, shaping of objects with diverse 3D structures, and creation of flexible, meter-long afterglow fibers. This work offers significant potential for practical applications in advanced textiles, displays, and other fields.

Identifiers

PMID40374693
PMCPMC12081614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.